<!---->
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Glob Heart</journal-id><journal-id journal-id-type="iso-abbrev">Glob Heart</journal-id><journal-id journal-id-type="issn">2211-8179</journal-id><journal-title-group><journal-title>Global Heart</journal-title></journal-title-group><issn pub-type="ppub">2211-8160</issn><issn pub-type="epub">2211-8179</issn><publisher><publisher-name>Ubiquity Press</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12101114</article-id><article-id pub-id-type="doi">10.5334/gh.1434</article-id><article-version>VoR</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Relationship Between Leptin and Heart Failure: A Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1409-4661</contrib-id><name><surname>Sun</surname><given-names>Xin</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-4482-5858</contrib-id><name><surname>Xin</surname><given-names>Caihong</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Yao</surname><given-names>Jiayi</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4506-306X</contrib-id><name><surname>Wang</surname><given-names>Hongli</given-names></name><email>hongliwang_doctor@163.com</email><xref rid="aff-3" ref-type="aff">3</xref></contrib></contrib-group><aff id="aff-1"><label>1</label>Department of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, CN</aff><aff id="aff-2"><label>2</label>Department of Endocrinology and Metabolism, The Fourth People&#x02019;s Hospital of Soochow University, Shenyang, CN</aff><aff id="aff-3"><label>3</label>Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, CN</aff><pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-05-23"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date publication-format="electronic" date-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>1</issue><elocation-id>44</elocation-id><history><date date-type="received" iso-8601-date="2024-10-10"><day>10</day><month>10</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-05-12"><day>12</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2025 The Author(s)</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See <uri xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</uri>.</license-p></license></permissions><self-uri xlink:href="https://globalheartjournal.com/articles/10.5334/gh.1434/"/><abstract><sec><title>Background:</title><p>Heart failure (HF) is a diverse and potentially fatal condition affecting more than 60 million people worldwide. Previous studies have identified a close relationship between leptin levels and HF, and that leptin levels in patients with HF are higher than those in healthy individuals. However, some studies have reported inconsistent results. Therefore, the association between leptin levels and HF remains controversial.</p></sec><sec sec-type="methods"><title>Methods:</title><p>A literature search was conducted on the Web of Science, Wiley Online Library, Embase, and PubMed databases. The title or abstract search term &#x02018;leptin&#x02019; was used in combination with &#x02018;heart failure&#x02019; and &#x02018;HF&#x02019;. Meta-analysis results were reported as standardized mean differences (SMD) with corresponding 95% confidence intervals (CI).</p></sec><sec><title>Results:</title><p>Eighteen studies comprising 1149 patients with HF and 622 healthy controls were included in the meta-analysis. Leptin levels in patients with HF were significantly higher than those in healthy individuals (SMD, 0.54; 95% CI [0.15, 0.93]).</p></sec><sec><title>Conclusions:</title><p>To our knowledge, this systematic review is the first to evaluate the relationship between leptin and HF. Determining the role of leptin in HF will significantly contribute to its diagnosis and treatment.</p></sec></abstract><kwd-group><kwd>leptin</kwd><kwd>heart failure</kwd><kwd>HF</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Heart failure (HF) is a diverse and potentially fatal condition affecting more than 60 million people worldwide. It is associated with significant illness and death, reduced quality of life, and substantial strain on healthcare resources, including usage and costs (<xref rid="B1" ref-type="bibr">1</xref>). Despite pharmacological treatment, the annual HF mortality rate exceeds 20% (<xref rid="B2" ref-type="bibr">2</xref>). Hence, early diagnosis and prognostic evaluation of patients with HF, along with appropriate interventions, are of utmost significance. Obesity is widely acknowledged as an independent risk factor for HF (<xref rid="B3" ref-type="bibr">3</xref>). Nevertheless, epidemiological investigations have revealed that obese HF patients may have a better prognosis than those with normal weight (<xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref>), a phenomenon referred to as the &#x02018;obesity paradox&#x02019; (<xref rid="B6" ref-type="bibr">6</xref>). The obesity paradox exists in multiple cardiovascular diseases, including myocardial infarction, hypertension, patients undergoing coronary artery bypass grafting, peripheral vascular diseases, atrial fibrillation, and aortic stenosis (<xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref><xref rid="B9" ref-type="bibr">9</xref>). Regardless of geographical setting, sex, age range, and presence of comorbidities, the medical community has reached a consensus that patients with HF and a higher BMI have relatively better prognoses (<xref rid="B10" ref-type="bibr">10</xref>). However, the mechanism underlying this paradoxical phenomenon remains unclear. It is thought that adipose tissue may play a crucial role. Adipose tissue has previously been regarded as an energy-storage organ; however, it is now considered an endocrine organ that secretes large quantities of adipokines, exerting effects on various organs and tissues.</p><p>Leptin, the first fat factor discovered, exists in particularly high levels in the blood of patients with obesity and myocardial infarction. Leptin primarily reduces cardiac output by exerting a negative inotropic effect on cardiomyocytes. It also regulates cardiac metabolism, cardiomyocyte morphology, and extracellular matrix production (<xref rid="B11" ref-type="bibr">11</xref>). Research has shown that the expression of transcriptional activator-3 (signal transducer and activator of transcription-3, STAT-3) and AMPK can be upregulated by leptin and its receptor in cardiomyocytes, thereby exerting cardioprotective effects on patients with HF by improving myocardial hypertrophy, reducing cell apoptosis, and controlling inflammatory responses (<xref rid="B12" ref-type="bibr">12</xref>).</p><p>Some studies reported that leptin levels in patients with HF were significantly lower than those in healthy individuals (<xref rid="B13" ref-type="bibr">13</xref><xref rid="B14" ref-type="bibr">14</xref>). However, the results of similar studies were inconsistent with those of earlier studies (<xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">16</xref>). Therefore, the relationship between leptin levels and HF remains controversial, and whether changes in leptin levels are related to HF remains unclear. Consequently, this meta-analysis aimed to systematically and comprehensively evaluate the relationship between leptin levels and HF.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Literature search</title><p>A literature search of the Web of Science, Wiley Online Library, PubMed, and Embase databases was performed. The search scope included studies investigating the relationship between leptin and patients with HF, up to October 2024. The title or abstract search term &#x02018;leptin&#x02019; was used in combination with &#x02018;heart failure&#x02019;. Eligible studies were restricted to those published in English. The reference lists of retrieved studies were manually searched to identify additional potentially eligible studies. The study was registered in the PROSPERO Database (CRD42024594741). All requisite items reported for systematic reviews and meta-analyses are listed in the Supplementary Data (File S1). Full search strategy in databases is also provided in Supplementary Data (File S2).</p></sec><sec><title>Inclusion criteria</title><p>The meta-analysis was performed on studies fulfilling the following criteria: sufficient data regarding leptin levels in patients with HF and healthy controls; a case-control design; and publication in English.</p></sec><sec><title>Exclusion criteria</title><p>Duplicate studies, those with insufficient data, animal studies, meta-analyses, reviews, meeting summaries, case reports, and editorials were excluded.</p></sec><sec><title>Data extraction and risk of bias</title><p>Two investigators (SX and YJY) independently reviewed the titles and abstracts of the retrieved studies according to predetermined inclusion and exclusion criteria. Disagreements regarding study selection during the review process were resolved through consensus discussion based on an established standard. If consensus could not be reached, a third investigator was invited to participate in the final decision as to whether the study fulfilled the inclusion criteria. Data extracted from the selected studies included the following: first author, publication year, research methods, sample size, age, sex, and population.</p><p>The Cochrane Collaboration recommends the Newcastle-Ottawa Scale (NOS) as a tool for assessing bias in observational studies (<xref rid="B17" ref-type="bibr">17</xref>). The NOS was used as an evaluation standard, and two researchers were based on the research content of the case-control studies and cohort studies, the methodological quality of independent evaluation, including selection of the research objective, comparability between groups, and outcome measures. An NOS score between 0 and 9 was calculated, with &#x02265;6 points considered to be a high-quality study; the higher the score, the higher the quality of the study (<xref rid="B18" ref-type="bibr">18</xref>).</p></sec><sec><title>Statistical analysis</title><p>The results are expressed as the standardized mean difference (SMD) with a corresponding 95% confidence interval (CI). Heterogeneity was assessed according to <italic toggle="yes">I</italic><sup>2</sup> and <italic toggle="yes">P</italic> values, as follows: <italic toggle="yes">I</italic><sup>2</sup> &#x0003c; 50% and <italic toggle="yes">P</italic> &#x0003e; 0.1 represented low heterogeneity and a fixed-effects model was used for analysis; <italic toggle="yes">I</italic><sup>2</sup> &#x02265; 50% and <italic toggle="yes">P</italic> &#x02264; 0.1 represented high heterogeneity and a random-effects model was used for analysis. Sensitivity analyses were performed for the sources of heterogeneity of the outcome indicators. Egger&#x02019;s and Begger&#x02019;s tests were used to assess publication bias. A <italic toggle="yes">P</italic> &#x0003c; 0.05 was considered statistically significant. Statistical analysis was performed using Stata 12.0 (StataCorp LLC, College Station, TX, USA).</p></sec></sec><sec><title>Results</title><sec><title>Literature search and study selection</title><p>In total, 1,394 relevant studies were retrieved from the Web of Science, Wiley Online Library, PubMed, and Embase databases. Finally, 18 studies comprising 1149 patients with HF and 622 healthy controls were included in the meta-analysis (<xref rid="B13" ref-type="bibr">13</xref><xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">16</xref><xref rid="B19" ref-type="bibr">19</xref><xref rid="B20" ref-type="bibr">20</xref><xref rid="B21" ref-type="bibr">21</xref><xref rid="B22" ref-type="bibr">22</xref><xref rid="B23" ref-type="bibr">23</xref><xref rid="B24" ref-type="bibr">24</xref><xref rid="B25" ref-type="bibr">25</xref><xref rid="B26" ref-type="bibr">26</xref><xref rid="B27" ref-type="bibr">27</xref><xref rid="B28" ref-type="bibr">28</xref><xref rid="B29" ref-type="bibr">29</xref><xref rid="B30" ref-type="bibr">30</xref><xref rid="B31" ref-type="bibr">31</xref><xref rid="B32" ref-type="bibr">32</xref>). A flow diagram illustrating the study selection process is shown in <xref rid="F1" ref-type="fig">Figure 1</xref>. The characteristics of the included studies are summarized in <xref rid="T1" ref-type="table">Table 1</xref>. All 18 studies included in this meta-analysis fulfilled the criteria for the not otherwise specified (NOS) categories of selection, comparability, and exposure.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Flowchart of the detailed procedure for the inclusion or exclusion of selected studies.</p></caption><alt-text>Flowchart of the detailed procedure</alt-text><graphic xlink:href="gh-20-1-1434-g1" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Study characteristics of the published studies included in the meta-analysis.</p></caption><table frame="hsides" rules="groups"><tr><th colspan="9" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="3" colspan="1">AUTHOR</th><th align="left" valign="top" rowspan="3" colspan="1">PUBLICATION YEAR</th><th align="left" valign="top" rowspan="3" colspan="1">REGION</th><th align="left" valign="top" colspan="2" rowspan="1">NUMBER</th><th align="left" valign="top" colspan="2" rowspan="1">LEPTIN</th><th align="left" valign="top" colspan="2" rowspan="1">DETAILS</th></tr><tr><th colspan="2" rowspan="1">
<hr/>
</th><th colspan="2" rowspan="1">
<hr/>
</th><th colspan="2" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">CASE</th><th align="left" valign="top" rowspan="1" colspan="1">CONTROL</th><th align="left" valign="top" rowspan="1" colspan="1">CASE</th><th align="left" valign="top" rowspan="1" colspan="1">CONTROL</th><th align="left" valign="top" rowspan="1" colspan="1">CASE</th><th align="left" valign="top" rowspan="1" colspan="1">CONTROL</th></tr><tr><th colspan="9" rowspan="1">
<hr/>
</th></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Toth MJ</td><td align="left" valign="top" rowspan="1" colspan="1">1997</td><td align="left" valign="top" rowspan="1" colspan="1">USA</td><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">5.1 &#x000b1; 4.2</td><td align="left" valign="top" rowspan="1" colspan="1">6.8 &#x000b1; 4.4</td><td align="left" valign="top" rowspan="1" colspan="1">Eighteen patients (aged 71 &#x000b1; 6 years) with HF were recruited. Ten patients with documented coronary artery disease and eight patients with dilated cardiomyopathy unrelated to coronary artery disease.</td><td align="left" valign="top" rowspan="1" colspan="1">Forty-six healthy elderly subjects (aged 66 &#x000b1; 6 years) served as a control group.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Leyva F</td><td align="left" valign="top" rowspan="1" colspan="1">1998</td><td align="left" valign="top" rowspan="1" colspan="1">Germany</td><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">8.12 &#x000b1; 1.3</td><td align="left" valign="top" rowspan="1" colspan="1">4.48 &#x000b1; 0.7</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 25 patients with congestive HF. Chronic HF was secondary to coronary heart disease in 13 and to idiopathic dilated cardiomyopathy in 12.</td><td align="left" valign="top" rowspan="1" colspan="1">Healthy controls were matched to congestive HF patients for age, sex, and total body fat.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Murdoch DR</td><td align="left" valign="top" rowspan="1" colspan="1">1999</td><td align="left" valign="top" rowspan="1" colspan="1">UK</td><td align="left" valign="top" rowspan="1" colspan="1">51</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">10.82 &#x000b1; 5.86</td><td align="left" valign="top" rowspan="1" colspan="1">18.3 &#x000b1; 3.5</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 51 patients, aged 52 to 83 years, with stable chronic HF of more than 3 months duration. The primary cause of HF was coronary artery disease in 48 patients and regurgitant valve disease in 3 patients.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 26 matched healthy volunteers, aged 30 to 76 years.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">El-Bindary EM</td><td align="left" valign="top" rowspan="1" colspan="1">2001</td><td align="left" valign="top" rowspan="1" colspan="1">Egypt</td><td align="left" valign="top" rowspan="1" colspan="1">80</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">16.94 &#x000b1; 6.33</td><td align="left" valign="top" rowspan="1" colspan="1">12.25 &#x000b1; 3.9</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 47 patients (aged 47 &#x000b1; 4 years) with chronic HF.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 20 aged- and sex-matched healthy volunteers.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Doehner W</td><td align="left" valign="top" rowspan="1" colspan="1">2001</td><td align="left" valign="top" rowspan="1" colspan="1">Germany</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">7.6 &#x000b1; 0.7</td><td align="left" valign="top" rowspan="1" colspan="1">4.8 &#x000b1; 0.7</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 47 patients (aged 61 &#x000b1; 2 years) with chronic HF due to ischemic heart disease (n = 28) or idiopathic dilated cardiomyopathy (n = 19).</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 21 healthy subjects (aged 59 &#x000b1; 3 years) of similar age.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Schulze PC</td><td align="left" valign="top" rowspan="1" colspan="1">2003</td><td align="left" valign="top" rowspan="1" colspan="1">Germany</td><td align="left" valign="top" rowspan="1" colspan="1">53</td><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">7.72 &#x000b1; 0.9</td><td align="left" valign="top" rowspan="1" colspan="1">6.36 &#x000b1; 1.35</td><td align="left" valign="top" rowspan="1" colspan="1">Patients (aged 71 &#x000b1; 6 years) with chronic HF as a result of dilated cardiomyopathy or ischemic heart disease were included in this study.</td><td align="left" valign="top" rowspan="1" colspan="1">A total of 11 age-matched patients (aged 61 &#x000b1; 4 years), who were admitted with non-specific chest pain for the exclusion of coronary artery disease, served as controls.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">McEntegart MB</td><td align="left" valign="top" rowspan="1" colspan="1">2007</td><td align="left" valign="top" rowspan="1" colspan="1">UK</td><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">11.57 &#x000b1; 4.98</td><td align="left" valign="top" rowspan="1" colspan="1">11.1 &#x000b1; 4.225</td><td align="left" valign="top" rowspan="1" colspan="1">Patients (aged 56.6 &#x000b1; 1.3 years) with HF as a result of coronary artery disease.</td><td align="left" valign="top" rowspan="1" colspan="1">Healthy controls (aged 60.4 &#x000b1; 4.0 years) were recruited from patient companions at the cardiology clinics. In addition to age-matching a lifestyle history was taken to activity-match healthy controls to the patients.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fernandes F</td><td align="left" valign="top" rowspan="1" colspan="1">2007</td><td align="left" valign="top" rowspan="1" colspan="1">Brazil</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">1.4 &#x000b1; 0.8</td><td align="left" valign="top" rowspan="1" colspan="1">8.1 &#x000b1; 7.8</td><td align="left" valign="top" rowspan="1" colspan="1">Patients (aged 47.8 &#x000b1; 9.1 years) with HF as a result of Chagas&#x02019; disease.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 30 healthy individuals (aged 43.9 &#x000b1; 5.9 years).</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patel JV</td><td align="left" valign="top" rowspan="1" colspan="1">2007</td><td align="left" valign="top" rowspan="1" colspan="1">UK</td><td align="left" valign="top" rowspan="1" colspan="1">101</td><td align="left" valign="top" rowspan="1" colspan="1">110</td><td align="left" valign="top" rowspan="1" colspan="1">7.90 &#x000b1; 3.42</td><td align="left" valign="top" rowspan="1" colspan="1">6.30 &#x000b1; 2.67</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of South Asian and European Caucasian descent patients with mild to moderate chronic HF.</td><td align="left" valign="top" rowspan="1" colspan="1">Age, gender and ethnically matched controls were recruited from relatives of patients, healthy hospital staff, and local community groups.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sierra-Johnson J</td><td align="left" valign="top" rowspan="1" colspan="1">2008</td><td align="left" valign="top" rowspan="1" colspan="1">USA</td><td align="left" valign="top" rowspan="1" colspan="1">135</td><td align="left" valign="top" rowspan="1" colspan="1">106</td><td align="left" valign="top" rowspan="1" colspan="1">13.2 &#x000b1; 12</td><td align="left" valign="top" rowspan="1" colspan="1">7.6 &#x000b1; 6</td><td align="left" valign="top" rowspan="1" colspan="1">One hundred thirty-five consecutively eligible white patients (aged 55.8 &#x000b1; 11 years) with a diagnosis of stable noncachectic systolic HF were recruited. The etiology of HF was ischemic or nonischemic dilated cardiomyopathy.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 104 healthy individuals (aged 53.8 &#x000b1; 15 years).</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Straburzy&#x00144;ska-Migaj E</td><td align="left" valign="top" rowspan="1" colspan="1">2010</td><td align="left" valign="top" rowspan="1" colspan="1">Poland</td><td align="left" valign="top" rowspan="1" colspan="1">41</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">9.2 &#x000b1; 7.5</td><td align="left" valign="top" rowspan="1" colspan="1">2.9 &#x000b1; 1.2</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 41 patients (aged 50.1 &#x000b1; 9.3 years) with HF. Coronary artery disease was diagnosed in 16 patients and dilated cardiomyopathy in the remaining 25 patients.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of eight healthy volunteers (aged 43.6 &#x000b1; 14.7 years) of a similar age and gender distribution to the patients with HF.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Schulze PCMP</td><td align="left" valign="top" rowspan="1" colspan="1">2011</td><td align="left" valign="top" rowspan="1" colspan="1">USA</td><td align="left" valign="top" rowspan="1" colspan="1">80</td><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">8.67 &#x000b1; 5.45</td><td align="left" valign="top" rowspan="1" colspan="1">3.7 &#x000b1; 2.7</td><td align="left" valign="top" rowspan="1" colspan="1">A total of 44 patients (aged 61 &#x000b1; 12 years) with acute decompensated HF, and 26 patients (aged 63 &#x000b1; 12 years) with chronic HF were enrolled in this study.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 21 healthy individuals (aged 57 &#x000b1; 13 years).</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bobbert P</td><td align="left" valign="top" rowspan="1" colspan="1">2012</td><td align="left" valign="top" rowspan="1" colspan="1">Germany</td><td align="left" valign="top" rowspan="1" colspan="1">104</td><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">13.38 &#x000b1; 16.53</td><td align="left" valign="top" rowspan="1" colspan="1">7.34 &#x000b1; 5.7</td><td align="left" valign="top" rowspan="1" colspan="1">A total of 52 patients (aged 48.3 &#x000b1; 13.3 years) with non-ischaemic dilated cardiomyopathy, and 52 patients (aged 49.3 &#x000b1; 14.3 years) with inflammatory cardiomyopathy were enrolled in this study.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group was comprised of patients (aged 40.4 &#x000b1; 7.7 years) admitted to the hospital for evaluation of suspected cardiomyopathy, in whom the diagnostic work-up finally revealed that their complaints were noncardiac in origin.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Karayannis G</td><td align="left" valign="top" rowspan="1" colspan="1">2013</td><td align="left" valign="top" rowspan="1" colspan="1">Greece</td><td align="left" valign="top" rowspan="1" colspan="1">57</td><td align="left" valign="top" rowspan="1" colspan="1">64</td><td align="left" valign="top" rowspan="1" colspan="1">9 &#x000b1; 10.3</td><td align="left" valign="top" rowspan="1" colspan="1">8.7 &#x000b1; 8.7</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 57 consecutive patients (aged 68 &#x000b1; 12 years) hospitalized for decompensated HF.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group was comprised of 64 age- and sex-matched asymptomatic individuals (aged 64 &#x000b1; 11 years).</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Loncar G</td><td align="left" valign="top" rowspan="1" colspan="1">2013</td><td align="left" valign="top" rowspan="1" colspan="1">Serbia</td><td align="left" valign="top" rowspan="1" colspan="1">73</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">7.3 &#x000b1; 6.7</td><td align="left" valign="top" rowspan="1" colspan="1">5.9 &#x000b1; 3.2</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 73 males (aged 68 &#x000b1; 7 years) with chronic HF due to ischaemic or idiopathic dilated cardiomyopathy.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 20 male volunteers (aged 67 &#x000b1; 7 years), without the history of any chronic disease and without any regular medication regimen.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Faxen UL</td><td align="left" valign="top" rowspan="1" colspan="1">2017</td><td align="left" valign="top" rowspan="1" colspan="1">Sweden</td><td align="left" valign="top" rowspan="1" colspan="1">163</td><td align="left" valign="top" rowspan="1" colspan="1">71</td><td align="left" valign="top" rowspan="1" colspan="1">19.17 &#x000b1; 26.02</td><td align="left" valign="top" rowspan="1" colspan="1">10.8 &#x000b1; 2.6</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 163 patients with HF.</td><td align="left" valign="top" rowspan="1" colspan="1">The control group consisted of 71 individuals without self-reported cardiovascular disease or known hypertension.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Shiina Y</td><td align="left" valign="top" rowspan="1" colspan="1">2018</td><td align="left" valign="top" rowspan="1" colspan="1">Japan</td><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">10.1 &#x000b1; 8.14</td><td align="left" valign="top" rowspan="1" colspan="1">10.3 &#x000b1; 3.5</td><td align="left" valign="top" rowspan="1" colspan="1">The study group consisted of 46 patients (aged 32.1 &#x000b1; 7.4 years) with HF due to congenital heart disease.</td><td align="left" valign="top" rowspan="1" colspan="1">Twelve age-matched healthy subjects (aged 31.5 &#x000b1; 7.2 years), all of whom were medical staff at our hospital and were enrolled as controls.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dabarian AL</td><td align="left" valign="top" rowspan="1" colspan="1">2019</td><td align="left" valign="top" rowspan="1" colspan="1">Brazil</td><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">5.28 &#x000b1; 4.45</td><td align="left" valign="top" rowspan="1" colspan="1">5.61 &#x000b1; 5.96</td><td align="left" valign="top" rowspan="1" colspan="1">A total of 15 patients (aged 42.67 &#x000b1; 6.72 years) with Chagas heart disease, and 16 patients (aged 46.2 &#x000b1; 8.12 years) with idiopathic dilated cardiomyopathy were enrolled in this study.</td><td align="left" valign="top" rowspan="1" colspan="1">Healthy controls (aged 48.3 &#x000b1; 7.48 years) were matched to HF patients for age, sex, and body mass index.</td></tr><tr><td colspan="11" rowspan="1">
<hr/>
</td></tr></table><table-wrap-foot><fn><p>HF, heart failure.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Results of meta-analysis</title><p>Leptin levels in patients with HF were significantly higher than those in healthy individuals (SMD: 0.54, 95% CI [0.15, 0.93]; <italic toggle="yes">I</italic><sup>2</sup> = 91.8%, <italic toggle="yes">P</italic> &#x0003c; 0.05). Forest plots of the results are shown in <xref rid="F2" ref-type="fig">Figure 2</xref>, and funnel plots are presented in Figure S1. We noted that the increase in leptin levels was more pronounced in patients with severe HF. However, because few studies on leptin levels in patients with different degrees of HF were available, we were unable to draw accurate conclusions.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>Forest plots of leptin level in patients with heart failure compared to healthy individuals. Diamond represents the pooled SMDs at 95% CI. SMD, standardized mean difference; CI, confidence interval.</p></caption><alt-text>Forest plots of leptin level in patients with heart failure</alt-text><graphic xlink:href="gh-20-1-1434-g2" position="float"/></fig></sec><sec><title>Sensitivity analysis and publication bias</title><p>To ensure the reliability of the results, the calculations were recalculated by stepwise elimination of &#x02265;1 studies and sensitivity analysis using a random-effects model. There was no significant change in the effect size after stepwise deletion of individual studies, indicating that the results were stable and reliable (<xref rid="F3" ref-type="fig">Figure 3</xref>). A thorough and comprehensive database search was performed. Tests for the presence of publication bias in the results of systematic reviews were performed. Begger&#x02019;s and Egger&#x02019;s tests were used to assess overall publication bias in the included studies, with no bias observed in any of the included studies.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>The sensitivity analysis results of leptin level in patients with heart failure compared to healthy individuals.</p></caption><alt-text>The sensitivity analysis results of leptinlevel</alt-text><graphic xlink:href="gh-20-1-1434-g3" position="float"/></fig></sec></sec><sec><title>Discussion</title><p>This systematic review is the first comprehensive evaluation of leptin levels in patients with HF. Eighteen independent case-control studies were included in this meta-analysis, and results showed that leptin levels in patients with HF were significantly higher than those in healthy controls. Fully characterizing the role of leptin in HF will contribute to clinical recommendations.</p><p>In 1994, Zhang et al. (<xref rid="B11" ref-type="bibr">11</xref>) cloned the mouse obesity gene (ob gene) from the adipose tissue of genetically obese mice (ob mice) for the first time, and Isse et al. successfully cloned the human obesity gene leptin (<xref rid="B33" ref-type="bibr">33</xref>). Six types of leptin receptors (Ob-Rb) have been identified, including Ob-Ra, Ob-Rb, Ob-Rc, Ob-Rd, Ob-Re, and Ob-Rf, of which Ob-Rb is the only long and functional receptor responsible for signal transduction in leptin cells. Ob-Rb has also been found in cardiomyocytes, indicating that leptin can act on the heart (<xref rid="B34" ref-type="bibr">34</xref>). Recent studies showed that the serum leptin concentrations in obese people were significantly higher than those in normal-weight people (<xref rid="B35" ref-type="bibr">35</xref>). Leptin mainly exists in a free state in obese individuals, and free leptin is generally believed to have biological activity (<xref rid="B36" ref-type="bibr">36</xref>).</p><p>At present, most researchers believe that excessive activation of neuroendocrine cytokines is an important cause of ventricular remodeling in HF. Ventricular remodeling is a complex process involving many factors. Previous studies suggested possible causes of elevated leptin levels in patients with HF. Swan et al. (<xref rid="B37" ref-type="bibr">37</xref>) and Doehner et al. (<xref rid="B38" ref-type="bibr">38</xref>) found that patients with chronic HF had hyperinsulinemia and insulin resistance. Insulin directly promoted leptin release from the endoplasmic reticulum of adipocytes (<xref rid="B39" ref-type="bibr">39</xref>). Animal experiments confirmed that insulin increased the expression of leptin RNA in adipose tissue and promoted protein secretion. Both short- and long-term insulin administration increased leptin gene expression. In HF, cardiac output is significantly decreased, and surrounding tissues and organs are not sufficiently perfused, causing ischemia and hypoxia, which are critical stress signals in the body. Stress leads to increased plasma cortisol levels in patients with HF failure. In vitro experiments confirmed that glucocorticoids directly or indirectly affected leptin secretion. Glucocorticoids can indirectly increase neuropeptide Y content in the hypothalamus, promoting ob gene expression. Glucocorticoids can also cause insulin resistance, manifesting as increased insulin secretion; thus, high insulin levels indirectly cause an increase in leptin levels (<xref rid="B40" ref-type="bibr">40</xref>). The kidney is the main organ responsible for the clearance of leptin, and damage to glomerular filtration or renal tubular reabsorption caused by various diseases can affect the clearance of leptin from the body, leading to leptin accumulation (<xref rid="B41" ref-type="bibr">41</xref>). Insufficient renal perfusion and decreased filtration rate in HF may be important factors in increased leptin levels.</p><p>High blood levels of leptin have been used to predict the severity of heart diseases, including HF (<xref rid="B42" ref-type="bibr">42</xref>). However, other studies showed an inverse relationship between plasma leptin levels and left ventricular mass (<xref rid="B43" ref-type="bibr">43</xref>). More compelling results supporting the role of leptin have been obtained from experimental studies. Most of these studies demonstrated a hypertrophic or cardiomyocyte hyperplasia response following leptin administration, indicating a direct hypertrophic effect (<xref rid="B44" ref-type="bibr">44</xref><xref rid="B45" ref-type="bibr">45</xref>). Myocardial overexpression during ischemia and reperfusion enhanced myocardial remodeling, leading to increased dysfunction (<xref rid="B46" ref-type="bibr">46</xref>). Furthermore, leptin influences myocardial remodeling by stimulating myocardial fibrosis, further contributing to the development of HF (<xref rid="B47" ref-type="bibr">47</xref>). Cardiomyocytes may be a target of leptin in circulation, and Nickola et al. have shown that leptin inhibited muscle contractility (<xref rid="B48" ref-type="bibr">48</xref>) leading to cardiac hypertrophy, a beneficial adaptive response in case of myocardial damage. However, continuous cardiac hypertrophy can lead to cardiac remodeling and the development of HF (<xref rid="B49" ref-type="bibr">49</xref>). Dong et al. showed that the effect of leptin on myocardial contractility in isolated rat cardiomyocytes was significantly attenuated by the ET-1 receptor blockers BQ123 and BQ788, and NADPH oxidase inhibitors. These results suggested that leptin inhibits myocardial contractions possibly through the ET-1 receptor and NADPH oxidase pathways (<xref rid="B50" ref-type="bibr">50</xref>). Adiarto et al. observed plasma ET-1 levels and myocardial ET-1M RNA expression by feeding ob gene-null mice and wild-type mice a high-fat diet (<xref rid="B51" ref-type="bibr">51</xref>). The results showed that plasma levels of ET-1 and leptin, and the expression of myocardial ET-1 mRNA, increased in wild-type mice. However, plasma ET-1 and myocardial ET-1 levels in ob gene-deletion mice were lower than those in wild-type mice. These results suggest that leptin mediates the upregulation of ET-1 mRNA, causing an increase in ET-1 levels.</p><p>Researchers believe that leptin can be used as a target for the treatment of heart disease and, in recent years, they have searched for leptin antagonists or inhibitors of leptin synthesis. In a study on HF rats, Na et al. found that CPU86017 (p-chlorobenzyl tetrahydrogen small protein) reversed myocardial changes caused by leptin through the ET-1 pathway (<xref rid="B52" ref-type="bibr">52</xref>). These findings may provide a research direction in the search for leptin antagonists.</p><p>Zeidan et al. demonstrated that leptin significantly activated RhoA in neonatal rat ventricular myocytes, and that activation was inhibited by an OBR antibody. Additionally, the hypertrophic effect was blocked by the inhibitors C3 exoenzyme and Y-27632, of RhoA and ROCK, respectively. They attributed the ROCK-dependent hypertrophic effect of leptin to an increase in actin polymerization, as indicated by a decrease in the G/F-actin ratio owing to LIM kinase-dependent cofilin phosphorylation (<xref rid="B53" ref-type="bibr">53</xref>). Their study also indicated that intact caveolae played a crucial role in RhoA/ROCK-dependent leptin-induced cardiomyocyte hypertrophy. Leptin significantly increases the expression of caveolae in cardiomyocytes, as confirmed by molecular analyses and electron microscopy. It is worth noting that OBR is co-localized with caveolae, and disrupting caveolae with the cholesterol-chelating agent methyl-&#x003b2;-cyclodextrin completely blocked the pro-hypertrophic effect of leptin. Additionally, the pro-hypertrophic effects of leptin in NRVMs were linked to the specific translocation of p38 MAPK into the nucleus, which was dependent on RhoA and caveolae, as demonstrated by a significant reduction in p38 MAPK nuclear translocation (<xref rid="B54" ref-type="bibr">54</xref>).</p><p>Central leptin has a two-fold impact on heart health, possibly causing ventricular atrophy and enhancing cardiac function in the presence of PPAR&#x003b2;/&#x003b4; signaling. The beneficial effects of leptin disappear with PPAR&#x003b2;/&#x003b4; suppression, highlighting the significance of this pathway (<xref rid="B55" ref-type="bibr">55</xref>).</p><p>The present study has some limitations. First, the methods used to measure leptin levels varied among the included studies. Second, different causes of HF may affect leptin levels. Third, patient characteristics, such as body weight, may have affected the analysis of the relationship between leptin and HF. Therefore, additional high-quality studies, especially prospective study, are required to further investigate the role of leptin in HF. Consequently, the results of the present meta-analysis should be interpreted with caution. Fully characterizing the role of leptin in HF will significantly contribute to diagnosis and improved treatment in clinical recommendations and guidelines.</p></sec><sec><title>Conclusion</title><p>To our knowledge, this systematic review is the first to evaluate the relationship between leptin and HF. Leptin levels were significantly higher in patients with HF. Fully characterizing the role of leptin in HF will significantly contribute to diagnosis and improved treatment.</p></sec><sec sec-type="data-availability"><title>Data Accessibility Statement</title><p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p></sec><sec sec-type="supplementary-material"><title>Additional Files</title><p>The additional files for this article can be found as follows:</p><supplementary-material id="supp1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.5334/gh.1434.s1</object-id><label>File S1.</label><caption><p>Preferred reporting items for systematic review and meta-analyses (PRISMA) checklist.</p></caption><media xlink:href="gh-20-1-1434-s1.pdf" id="d67e899" position="anchor"/></supplementary-material><supplementary-material id="supp2" position="float" content-type="local-data"><object-id pub-id-type="doi">10.5334/gh.1434.s2</object-id><label>File S2.</label><caption><p>Search strategy in databases.</p></caption><media xlink:href="gh-20-1-1434-s2.pdf" id="d67e906" position="anchor"/></supplementary-material><supplementary-material id="supp3" position="float" content-type="local-data"><object-id pub-id-type="doi">10.5334/gh.1434.s3</object-id><label>Figure S1.</label><caption><p>Funnel plots of leptin level in patients with heart failure compared to healthy individuals.</p></caption><media xlink:href="gh-20-1-1434-s3.pdf" id="d67e913" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>We would like to thank Editage (<ext-link xlink:href="https://www.editage.cn" ext-link-type="uri">www.editage.cn</ext-link>) for English language editing.</p></ack><sec sec-type="COI-statement"><title>Competing Interests</title><p>The authors have no competing interests to declare.</p></sec><sec><title>Author Contributions</title><p>WHL designed the study. SX searched databases and collected the data. SX and YJY assessed the quality of the study. WHL and YJY performed the analysis. XCH and SX wrote the manuscript. All authors contributed to this systematic review and meta-analysis.</p><p>Xin Sun and Caihong Xin contributed equally to this work.</p></sec><ref-list><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Savarese</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Becher</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Lund</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Seferovic</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rosano</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Coats</surname>
<given-names>A</given-names></string-name>. <article-title>Global burden of heart failure: A comprehensive and updated review of epidemiology</article-title>. <source>Cardiovascular Research</source>. <year>2023</year>;<volume>118</volume>(<issue>17</issue>):<fpage>3272</fpage>&#x02013;<lpage>3287</lpage>. DOI: <pub-id pub-id-type="doi">10.1093/cvr/cvac013</pub-id><pub-id pub-id-type="pmid">35150240</pub-id>
</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="book"><collab>American Heart Association</collab>. <source>Heart Disease and Stroke Statistics: 2003 Update</source>. <publisher-loc>Dallas, TX</publisher-loc>: <publisher-name>American Heart Association</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Kenchaiah</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Levy</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>PW</given-names></string-name>, <string-name><surname>Benjamin</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Larson</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Kannel</surname>
<given-names>WB</given-names></string-name>, <string-name><surname>Vasan</surname>
<given-names>RS</given-names></string-name>. <article-title>Obesity and the risk of heart failure</article-title>. <source>The New England Journal of Medicine</source>. <year>2002</year>;<volume>347</volume>(<issue>5</issue>):<fpage>305</fpage>&#x02013;<lpage>313</lpage>. DOI: <pub-id pub-id-type="doi">10.1056/NEJMoa020245</pub-id><pub-id pub-id-type="pmid">12151467</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Lavie</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Osman</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Milani</surname>
<given-names>RV</given-names></string-name>, <string-name><surname>Mehra</surname>
<given-names>MR</given-names></string-name>. <article-title>Body composition and prognosis in chronic systolic heart failure: The obesity paradox</article-title>. <source>American Journal of Cardiology</source>. <year>2003</year>;<volume>91</volume>(<issue>7</issue>):<fpage>891</fpage>&#x02013;<lpage>894</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/S0002-9149(03)00031-6</pub-id><pub-id pub-id-type="pmid">12667583</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Horwich</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Fonarow</surname>
<given-names>GC</given-names></string-name>. <article-title>The impact of obesity on survival in patients with heart failure</article-title>. <source>Heart Failure Monitor</source>. <year>2002</year>;<volume>3</volume>:<fpage>8</fpage>&#x02013;<lpage>14</lpage>. DOI: <pub-id pub-id-type="doi">10.1054/jcaf.2002.0804216</pub-id><pub-id pub-id-type="pmid">12634883</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Andreotti</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Rio</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lavorgna</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Coluzzi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Santucci</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cecchetti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pennestri</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Crea</surname>
<given-names>F</given-names></string-name>. <article-title>Body mass index and cardiovascular events: the &#x0201c;obesity paradox&#x0201d;</article-title>. <source>Recenti Progressi in Medicina</source>. <year>2009</year>;<volume>100</volume>(<issue>10</issue>):<fpage>447</fpage>&#x02013;<lpage>450</lpage>.<pub-id pub-id-type="pmid">20030166</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Lavie</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Milani</surname>
<given-names>RV</given-names></string-name>, <string-name><surname>Ventura</surname>
<given-names>HO</given-names></string-name>. <article-title>Obesity and the &#x0201c;obesity paradox&#x0201d; in cardiovascular diseases</article-title>. <source>Clinical Pharmacology &#x00026; Therapeutics</source>. <year>2011</year>;<volume>90</volume>(<issue>1</issue>):<fpage>23</fpage>&#x02013;<lpage>25</lpage>. DOI: <pub-id pub-id-type="doi">10.1038/clpt.2011.87</pub-id><pub-id pub-id-type="pmid">21691270</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Zafrir</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Adir</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shehadeh</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Shteinberg</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Salman</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Amir</surname>
<given-names>O</given-names></string-name>. <article-title>The association between obesity, mortality and filling pressures in pulmonary hypertension patients: The &#x0201c;obesity paradox&#x0201d;</article-title>. <source>Respiratory Medicine</source>. <year>2013</year>;<volume>107</volume>(<issue>1</issue>):<fpage>139</fpage>&#x02013;<lpage>146</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.rmed.2012.10.019</pub-id><pub-id pub-id-type="pmid">23199841</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Stamou</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Nussbaum</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stiegel</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Reames</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Skipper</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Robicsek</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lobdell</surname>
<given-names>KW</given-names></string-name>. <article-title>Effect of body mass index on outcomes after cardiac surgery: Is there an obesity paradox?</article-title>
<source>The Annals of Thoracic Surgery</source>. <year>2011</year>;<volume>91</volume>(<issue>1</issue>):<fpage>42</fpage>&#x02013;<lpage>47</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.athoracsur.2010.08.047</pub-id><pub-id pub-id-type="pmid">21172483</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Goel</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lopez-Jimenez</surname>
<given-names>F</given-names></string-name>, <string-name><surname>De Schutter</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Coutinho</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lavie</surname>
<given-names>CJ</given-names></string-name>. <article-title>Obesity paradox in different populations: Evidence and controversies</article-title>. <source>Future Cardiology</source>. <year>2014</year>;<volume>10</volume>(<issue>1</issue>):<fpage>81</fpage>&#x02013;<lpage>91</lpage>. DOI: <pub-id pub-id-type="doi">10.2217/fca.13.84</pub-id><pub-id pub-id-type="pmid">24344665</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Proenca</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Maffei</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barone</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Leopold</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Friedman</surname>
<given-names>JM</given-names></string-name>. <article-title>Positional cloning of the mouse obese gene and its human homologue</article-title>. <source>Nature</source>. <year>1994</year>;<volume>372</volume>(<issue>6505</issue>):<fpage>425</fpage>&#x02013;<lpage>432</lpage>. DOI: <pub-id pub-id-type="doi">10.1038/372425a0</pub-id><pub-id pub-id-type="pmid">7984236</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>McGaffin</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Witham</surname>
<given-names>WG</given-names></string-name>, <string-name><surname>Yester</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Romano</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>O&#x02019;Doherty</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>McTiernan</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>O&#x02019;Donnell</surname>
<given-names>CP</given-names></string-name>. <article-title>Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice</article-title>. <source>Cardiovascular Research</source>. <year>2011</year>;<volume>89</volume>(<issue>1</issue>):<fpage>60</fpage>&#x02013;<lpage>71</lpage>. DOI: <pub-id pub-id-type="doi">10.1093/cvr/cvq288</pub-id><pub-id pub-id-type="pmid">20833647</pub-id>
</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Leyva</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Anker</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Egerer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Stevenson</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Kox</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Coats</surname>
<given-names>AJ</given-names></string-name>. <article-title>Hyperleptinaemia in chronic heart failure. Relationships with insulin</article-title>. <source>European Heart Journal</source>. <year>1998</year>;<volume>19</volume>(<issue>10</issue>):<fpage>1547</fpage>&#x02013;<lpage>1551</lpage>. DOI: <pub-id pub-id-type="doi">10.1053/euhj.1998.1045</pub-id><pub-id pub-id-type="pmid">9820994</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>El-Bindary</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Darwish</surname>
<given-names>AZ</given-names></string-name>. <article-title>New biochemical markers in chronic heart failure</article-title>. <source>East Mediterranean Health Journal</source>. <year>2001</year>;<volume>7</volume>(<issue>4&#x02013;5</issue>):<fpage>697</fpage>&#x02013;<lpage>706</lpage>. DOI: <pub-id pub-id-type="doi">10.26719/2001.7.4-5.697</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Toth</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Fisher</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Nicklas</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Poehlman</surname>
<given-names>ET</given-names></string-name>. <article-title>Plasma leptin concentrations and energy expenditure in heart failure patients</article-title>. <source>Metabolism: Clinical and Experimental</source>. <year>1997</year>;<volume>46</volume>(<issue>4</issue>):<fpage>450</fpage>&#x02013;<lpage>453</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/S0026-0495(97)90065-2</pub-id><pub-id pub-id-type="pmid">9109853</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Murdoch</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Rooney</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Dargie</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Shapiro</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Morton</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>McMurray</surname>
<given-names>JJ</given-names></string-name>. <article-title>Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure</article-title>. <source>Heart</source>. <year>1999</year>;<volume>82</volume>(<issue>3</issue>):<fpage>352</fpage>&#x02013;<lpage>356</lpage>. DOI: <pub-id pub-id-type="doi">10.1136/hrt.82.3.352</pub-id><pub-id pub-id-type="pmid">10455089</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="webpage"><string-name><surname>Wells</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Shea</surname>
<given-names>B</given-names></string-name>, <string-name><surname>O&#x02019;Connell</surname>
<given-names>D</given-names></string-name>, et al. <source>The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses</source> [Accessed 2014 Aug 5]. Available from: <uri xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</uri>.</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="webpage"><string-name><surname>Higgins</surname>
<given-names>JPT</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>S</given-names></string-name>. <source>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0</source> [Accessed 2014 Aug]. Available from: <uri xlink:href="http://www.cochrane-handbook.org">http://www.cochrane-handbook.org</uri>.</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Doehner</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Pflaum</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Rauchhaus</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Godsland</surname>
<given-names>IF</given-names></string-name>, <string-name><surname>Egerer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Cicoira</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Florea</surname>
<given-names>VG</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bolger</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Coats</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Anker</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Strasburger</surname>
<given-names>CJ</given-names></string-name>. <article-title>Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia</article-title>. <source>European Journal of Endocrinology</source>. <year>2001</year>;<volume>145</volume>(<issue>6</issue>):<fpage>727</fpage>&#x02013;<lpage>735</lpage>. DOI: <pub-id pub-id-type="doi">10.1530/eje.0.1450727</pub-id><pub-id pub-id-type="pmid">11720897</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Schulze</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Kratzsch</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Linke</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schoene</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Adams</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gielen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Erbs</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Moebius-Winkler</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schuler</surname>
<given-names>G</given-names></string-name>. <article-title>Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure</article-title>. <source>European Journal of Heart Failure</source>. <year>2003</year>;<volume>5</volume>(<issue>1</issue>):<fpage>33</fpage>&#x02013;<lpage>40</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/S1388-9842(02)00177-0</pub-id><pub-id pub-id-type="pmid">12559213</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>McEntegart</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Awede</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Petrie</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Sattar</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Dunn</surname>
<given-names>FG</given-names></string-name>, <string-name><surname>MacFarlane</surname>
<given-names>NG</given-names></string-name>, <string-name><surname>McMurray</surname>
<given-names>JJ</given-names></string-name>. <article-title>Increase in serum adiponectin concentration in patients with heart failure and cachexia: Relationship with leptin, other cytokines, and B-type natriuretic peptide</article-title>. <source>European Heart Journal</source>. <year>2007</year>;<volume>28</volume>(<issue>7</issue>):<fpage>829</fpage>&#x02013;<lpage>835</lpage>. DOI: <pub-id pub-id-type="doi">10.1093/eurheartj/ehm033</pub-id><pub-id pub-id-type="pmid">17403719</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Fernandes</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Dantas</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ianni</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Ramires</surname>
<given-names>FJA</given-names></string-name>, <string-name><surname>Buck</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Salemi</surname>
<given-names>VMC</given-names></string-name>, <string-name><surname>Lopes</surname>
<given-names>HF</given-names></string-name>, <string-name><surname>Mady</surname>
<given-names>C</given-names></string-name>. <article-title>Leptin levels in different forms of Chagas&#x02019; disease</article-title>. <source>Brazilian Journal of Medical and Biological Research</source>. <year>2007</year>;<volume>40</volume>(<issue>12</issue>):<fpage>1631</fpage>&#x02013;<lpage>1636</lpage>. DOI: <pub-id pub-id-type="doi">10.1590/S0100-879X2006005000152</pub-id><pub-id pub-id-type="pmid">17713658</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Patel</surname>
<given-names>JV</given-names></string-name>, <string-name><surname>Sosin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Panja</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Hughes</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Lip</surname>
<given-names>GYH</given-names></string-name>. <article-title>Raised leptin concentrations among South Asian patients with chronic heart failure</article-title>. <source>International Journal of Cardiology</source>. <year>2007</year>;<volume>122</volume>(<issue>1</issue>):<fpage>34</fpage>&#x02013;<lpage>40</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.ijcard.2006.11.013</pub-id><pub-id pub-id-type="pmid">17187880</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Sierra-Johnson</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Romero-Corral</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Somers</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Olson</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>BD</given-names></string-name>. <article-title>Leptin, a novel predictor of lung function in heart failure</article-title>. <source>Chest</source>. <year>2008</year>;<volume>134</volume>(<issue>2</issue>):<fpage>346</fpage>&#x02013;<lpage>350</lpage>. DOI: <pub-id pub-id-type="doi">10.1378/chest.07-2751</pub-id><pub-id pub-id-type="pmid">18403666</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Straburzy&#x00144;ska-Migaj</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gwizda&#x00142;a</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Siniawski</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ochotny</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Grajek</surname>
<given-names>S</given-names></string-name>. <article-title>Leptin and inflammation in patients with chronic heart failure</article-title>. <source>Kardiologia Polska</source>. <year>2010</year>;<volume>68</volume>(<issue>11</issue>):<fpage>1243</fpage>.<pub-id pub-id-type="pmid">21108202</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Schulze</surname>
<given-names>PCMP</given-names></string-name>, <string-name><surname>Biolo</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Gopal</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Shahzad</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Balog</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Fish</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Siwik</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Colucci</surname>
<given-names>WSM</given-names></string-name>. <article-title>Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure</article-title>. <source>Journal of Cardiac Failure</source>. <year>2011</year>;<volume>17</volume>(<issue>12</issue>):<fpage>1004</fpage>&#x02013;<lpage>1011</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.cardfail.2011.08.010</pub-id><pub-id pub-id-type="pmid">22123363</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Bozic</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Loncar</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Prodanovic</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Radojicic</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Cvorovic</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Dimkovic</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Popovic-Brkic</surname>
<given-names>V</given-names></string-name>. <article-title>Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure</article-title>. <source>Journal of Cardiac Failure</source>. <year>2010</year>;<volume>16</volume>(<issue>4</issue>):<fpage>301</fpage>&#x02013;<lpage>307</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.cardfail.2009.12.015</pub-id><pub-id pub-id-type="pmid">20350696</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Karayannis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Giamouzis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tziolas</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Georgoulias</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Skoularigis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mikhailidis</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Triposkiadis</surname>
<given-names>F</given-names></string-name>. <article-title>Association between epicardial fat thickness and weight homeostasis hormones in patients with noncachectic heart failure</article-title>. <source>Angiology</source>. <year>2013</year>;<volume>64</volume>(<issue>3</issue>):<fpage>173</fpage>&#x02013;<lpage>180</lpage>. DOI: <pub-id pub-id-type="doi">10.1177/0003319712447978</pub-id><pub-id pub-id-type="pmid">22649110</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Loncar</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bozic</surname>
<given-names>B</given-names></string-name>, <string-name><surname>von Haehling</surname>
<given-names>S</given-names></string-name>, <string-name><surname>D&#x000fc;ngen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Prodanovic</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Lainscak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Arandjelovic</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dimkovic</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Radojicic</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Popovic</surname>
<given-names>V</given-names></string-name>. <article-title>Association of adiponectin with peripheral muscle status in elderly patients with heart failure</article-title>. <source>European Journal of Internal Medicine</source>. <year>2013</year>;<volume>24</volume>(<issue>8</issue>):<fpage>818</fpage>&#x02013;<lpage>823</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.ejim.2013.09.011</pub-id><pub-id pub-id-type="pmid">24095654</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Faxen</surname>
<given-names>UL</given-names></string-name>, <string-name><surname>Hage</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Andreasson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Donal</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Daubert</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Linde</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Brismar</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lund</surname>
<given-names>LH</given-names></string-name>. <article-title>HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin</article-title>. <source>International Journal of Cardiology</source>. <year>2017</year>;228:<fpage>709</fpage>&#x02013;<lpage>716</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.ijcard.2016.11.194</pub-id><pub-id pub-id-type="pmid">27886615</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Shiina</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Murakami</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Matsumoto</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Okamura</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Nishihata</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Komiyama</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Niwa</surname>
<given-names>K</given-names></string-name>. <article-title>Body composition, appetite-related hormones, adipocytokines, and heart failure in adult patients with congenital heart disease: A preliminary study</article-title>. <source>Congenital Heart Disease</source>. <year>2018</year>;<volume>13</volume>(<issue>1</issue>):<fpage>79</fpage>&#x02013;<lpage>84</lpage>. DOI: <pub-id pub-id-type="doi">10.1111/chd.12555</pub-id><pub-id pub-id-type="pmid">29181895</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Dabarian</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Mady</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Barbosa-Ferreira</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Ianni</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Hotta</surname>
<given-names>VT</given-names></string-name>, <string-name><surname>Ramires</surname>
<given-names>FJA</given-names></string-name>, <string-name><surname>Lopes</surname>
<given-names>HF</given-names></string-name>, <string-name><surname>Buck</surname>
<given-names>PDC</given-names></string-name>, <string-name><surname>Pessoa</surname>
<given-names>FG</given-names></string-name>, <string-name><surname>Fonseca</surname>
<given-names>KCB</given-names></string-name>, <string-name><surname>Nogueira</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Fernandes</surname>
<given-names>F</given-names></string-name>. <article-title>Dysregulation of insulin levels in Chagas heart disease is associated with altered adipocytokine levels</article-title>. <source>Canadian Journal of Physiology and Pharmacology</source>. <year>2019</year>;<volume>97</volume>(<issue>2</issue>):<fpage>140</fpage>&#x02013;<lpage>145</lpage>. DOI: <pub-id pub-id-type="doi">10.1139/cjpp-2018-0349</pub-id><pub-id pub-id-type="pmid">30557036</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Isse</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ogawa</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Tamura</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Masuzaki</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mori</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Okazaki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Satoh</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Shigemoto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yoshimasa</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Nishi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Et</surname>
<given-names>A</given-names></string-name>. <article-title>Structural organization and chromosomal assignment of the human obese gene</article-title>. <source>Journal of Biological Chemistry</source>. <year>1995</year>;<volume>270</volume>(<issue>46</issue>):<fpage>27728</fpage>&#x02013;<lpage>27733</lpage>. DOI: <pub-id pub-id-type="doi">10.1074/jbc.270.46.27728</pub-id><pub-id pub-id-type="pmid">7499240</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Schroeter</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Schneiderman</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Schumann</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Gluckermann</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Grimmas</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Buchwald</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Tirilomis</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Schondube</surname>
<given-names>FA</given-names></string-name>, <string-name><surname>Konstantinides</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Schafer</surname>
<given-names>K</given-names></string-name>. <article-title>Expression of the leptin receptor in different types of vascular lesions</article-title>. <source>Histochemistry and Cell Biology</source>. <year>2007</year>;<volume>128</volume>(<issue>4</issue>):<fpage>323</fpage>&#x02013;<lpage>333</lpage>. DOI: <pub-id pub-id-type="doi">10.1007/s00418-007-0319-1</pub-id><pub-id pub-id-type="pmid">17680264</pub-id>
</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Montague</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>Farooqi</surname>
<given-names>IS</given-names></string-name>, <string-name><surname>Whitehead</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Soos</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Rau</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wareham</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Sewter</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Digby</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Mohammed</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Hurst</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Cheetham</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Earley</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Barnett</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Prins</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>O&#x02019;Rahilly</surname>
<given-names>S</given-names></string-name>. <article-title>Congenital leptin deficiency is associated with severe early-onset obesity in humans</article-title>. <source>Nature</source>. <year>1997</year>;<volume>387</volume>(<issue>6636</issue>):<fpage>903</fpage>&#x02013;<lpage>908</lpage>. DOI: <pub-id pub-id-type="doi">10.1038/43185</pub-id><pub-id pub-id-type="pmid">9202122</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Thompson</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Ravussin</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bennett</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Bogardus</surname>
<given-names>C</given-names></string-name>. <article-title>Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians</article-title>. <source>Human Molecular Genetics</source>. <year>1997</year>;<volume>6</volume>(<issue>5</issue>):<fpage>675</fpage>&#x02013;<lpage>679</lpage>. DOI: <pub-id pub-id-type="doi">10.1093/hmg/6.5.675</pub-id><pub-id pub-id-type="pmid">9158141</pub-id>
</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Swan</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Anker</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Walton</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Godsland</surname>
<given-names>IF</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Leyva</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Stevenson</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Coats</surname>
<given-names>AJ</given-names></string-name>. <article-title>Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure</article-title>. <source>Journal of American College of Cardiology</source>. <year>1997</year>;<volume>30</volume>(<issue>2</issue>):<fpage>527</fpage>&#x02013;<lpage>532</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/S0735-1097(97)00185-X</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Doehner</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Rauchhaus</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Godsland</surname>
<given-names>IF</given-names></string-name>, <string-name><surname>Egerer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Niebauer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Cicoira</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Florea</surname>
<given-names>VG</given-names></string-name>, <string-name><surname>Coats</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Anker</surname>
<given-names>SD</given-names></string-name>. <article-title>Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha</article-title>. <source>International Journal of Cardiology</source>. <year>2002</year>;<volume>83</volume>(<issue>1</issue>):<fpage>73</fpage>&#x02013;<lpage>81</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/S0167-5273(02)00022-0</pub-id><pub-id pub-id-type="pmid">11959387</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Barr</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Malide</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zarnowski</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>SI</given-names></string-name>, <string-name><surname>Cushman</surname>
<given-names>SW</given-names></string-name>. <article-title>Insulin stimulates both leptin secretion and production by rat white adipose tissue</article-title>. <source>Endocrinology</source>. <year>1997</year>;<volume>138</volume>(<issue>10</issue>):<fpage>4463</fpage>&#x02013;<lpage>4472</lpage>. DOI: <pub-id pub-id-type="doi">10.1210/endo.138.10.5451</pub-id><pub-id pub-id-type="pmid">9322964</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Larsson</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ahren</surname>
<given-names>B</given-names></string-name>. <article-title>Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women</article-title>. <source>The Journal of Clinical Endocrinology &#x00026; Metabolism</source>. <year>1996</year>;<volume>81</volume>(<issue>12</issue>):<fpage>4428</fpage>&#x02013;<lpage>4432</lpage>. DOI: <pub-id pub-id-type="doi">10.1210/jc.81.12.4428</pub-id><pub-id pub-id-type="pmid">8954054</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Nordfors</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lonnqvist</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Heimburger</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Danielsson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schalling</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stenvinkel</surname>
<given-names>P</given-names></string-name>. <article-title>Low leptin gene expression and hyperleptinemia in chronic renal failure</article-title>. <source>Kidney International</source>. <year>1998</year>;<volume>54</volume>(<issue>4</issue>):<fpage>1267</fpage>&#x02013;<lpage>1275</lpage>. DOI: <pub-id pub-id-type="doi">10.1046/j.1523-1755.1998.00088.x</pub-id><pub-id pub-id-type="pmid">9767543</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Wannamethee</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Shaper</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Whincup</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Lennon</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sattar</surname>
<given-names>N</given-names></string-name>. <article-title>Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: Does leptin have a role?</article-title>
<source>Journal of American College of Cardiology</source>. <year>2011</year>;<volume>58</volume>(<issue>18</issue>):<fpage>1870</fpage>&#x02013;<lpage>1877</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.jacc.2011.06.057</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><string-name><surname>Pladevall</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Guyer</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sadurni</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Falces</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ribes</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pare</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Brotons</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gabriel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Serrano-Rios</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Haffner</surname>
<given-names>S</given-names></string-name>. <article-title>The association between leptin and left ventricular hypertrophy: A population-based cross-sectional study</article-title>. <source>Journal of Hypertension</source>. <year>2003</year>;<volume>21</volume>(<issue>8</issue>):<fpage>1467</fpage>&#x02013;<lpage>1473</lpage>. DOI: <pub-id pub-id-type="doi">10.1097/00004872-200308000-00009</pub-id><pub-id pub-id-type="pmid">12872039</pub-id>
</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><string-name><surname>Rajapurohitam</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gan</surname>
<given-names>XT</given-names></string-name>, <string-name><surname>Kirshenbaum</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Karmazyn</surname>
<given-names>M</given-names></string-name>. <article-title>The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes</article-title>. <source>Circulation Research</source>. <year>2003</year>;<volume>93</volume>(<issue>4</issue>):<fpage>277</fpage>&#x02013;<lpage>279</lpage>. DOI: <pub-id pub-id-type="doi">10.1161/01.RES.0000089255.37804.72</pub-id><pub-id pub-id-type="pmid">12893740</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><string-name><surname>Tajmir</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ceddia</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Coe</surname>
<given-names>IR</given-names></string-name>, <string-name><surname>Sweeney</surname>
<given-names>G</given-names></string-name>. <article-title>Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase-and phosphatidylinositol 3-kinase-dependent signaling pathways</article-title>. <source>Endocrinology</source>. <year>2004</year>;<volume>145</volume>(<issue>4</issue>):<fpage>1550</fpage>&#x02013;<lpage>1555</lpage>. DOI: <pub-id pub-id-type="doi">10.1210/en.2003-1128</pub-id><pub-id pub-id-type="pmid">14715711</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><string-name><surname>Kain</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Simon</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Greenberg</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ben</surname>
<given-names>ZD</given-names></string-name>, <string-name><surname>Gilburd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Schneiderman</surname>
<given-names>J</given-names></string-name>. <article-title>Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>10</issue>):e203902. DOI: <pub-id pub-id-type="doi">10.1371/journal.pone.0203902</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><string-name><surname>Mao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Sheng</surname>
<given-names>Y</given-names></string-name>. <article-title>The emerging role of leptin in obesity-associated cardiac fibrosis: Evidence and mechanism</article-title>. <source>Molecular and Cellular Biochemistry</source>. <year>2023</year>;<volume>478</volume>(<issue>5</issue>):<fpage>991</fpage>&#x02013;<lpage>1011</lpage>. DOI: <pub-id pub-id-type="doi">10.1007/s11010-022-04562-6</pub-id><pub-id pub-id-type="pmid">36214893</pub-id>
</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><string-name><surname>Nickola</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Wold</surname>
<given-names>LE</given-names></string-name>, <string-name><surname>Colligan</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Samson</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>J</given-names></string-name>. <article-title>Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO</article-title>. <source>Hypertension</source>. <year>2000</year>;<volume>36</volume>(<issue>4</issue>):<fpage>501</fpage>&#x02013;<lpage>505</lpage>. DOI: <pub-id pub-id-type="doi">10.1161/01.HYP.36.4.501</pub-id><pub-id pub-id-type="pmid">11040226</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><string-name><surname>Katz</surname>
<given-names>AM</given-names></string-name>. <article-title>Maladaptive growth in the failing heart: the cardiomyopathy of overload</article-title>. <source>Cardiovascular Drugs and Therapy</source>. <year>2002</year>;<volume>16</volume>(<issue>3</issue>):<fpage>245</fpage>&#x02013;<lpage>249</lpage>. DOI: <pub-id pub-id-type="doi">10.1023/A:1020604623427</pub-id><pub-id pub-id-type="pmid">12374903</pub-id>
</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><string-name><surname>Dong</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>J</given-names></string-name>. <article-title>Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway</article-title>. <source>Hypertension</source>. <year>2006</year>;<volume>47</volume>(<issue>2</issue>):<fpage>222</fpage>&#x02013;<lpage>229</lpage>. DOI: <pub-id pub-id-type="doi">10.1161/01.HYP.0000198555.51645.f1</pub-id><pub-id pub-id-type="pmid">16380530</pub-id>
</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><string-name><surname>Adiarto</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Emoto</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Iwasa</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>M</given-names></string-name>. <article-title>Obesity-induced upregulation of myocardial endothelin-1 expression is mediated by leptin</article-title>. <source>Biochemical and Biophysical Research Communications</source>. <year>2007</year>;<volume>353</volume>(<issue>3</issue>):<fpage>623</fpage>&#x02013;<lpage>627</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.12.066</pub-id><pub-id pub-id-type="pmid">17194443</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><string-name><surname>Na</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>DZ</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>Y</given-names></string-name>. <article-title>Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017</article-title>. <source>Naunyn-Schmiedeberg&#x02019;s Archives of Pharmacology</source>. <year>2007</year>;<volume>375</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>49</lpage>. DOI: <pub-id pub-id-type="doi">10.1007/s00210-007-0134-1</pub-id><pub-id pub-id-type="pmid">17287947</pub-id>
</mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><string-name><surname>Zeidan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Javadov</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Karmazyn</surname>
<given-names>M</given-names></string-name>. <article-title>Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes</article-title>. <source>Cardiovascular Research</source>. <year>2006</year>;<volume>72</volume>(<issue>1</issue>):<fpage>101</fpage>&#x02013;<lpage>111</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.cardiores.2006.06.024</pub-id><pub-id pub-id-type="pmid">16901475</pub-id>
</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><string-name><surname>Zeidan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Javadov</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chakrabarti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Karmazyn</surname>
<given-names>M</given-names></string-name>. <article-title>Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei</article-title>. <source>Cardiovascular Research</source>. <year>2008</year>;<volume>77</volume>(<issue>1</issue>):<fpage>64</fpage>&#x02013;<lpage>72</lpage>. DOI: <pub-id pub-id-type="doi">10.1093/cvr/cvm020</pub-id><pub-id pub-id-type="pmid">18006472</pub-id>
</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><string-name><surname>Rubio</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Pintado</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mazuecos</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Benito</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Andres</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gallardo</surname>
<given-names>N</given-names></string-name>. <article-title>Central actions of leptin induce an atrophic pattern and improves heart function in lean normoleptinemic rats via PPARbeta/delta activation</article-title>. <source>Biomolecules</source>. <year>2024</year>;<volume>14</volume>(<issue>8</issue>):<fpage>1028</fpage>. DOI: <pub-id pub-id-type="doi">10.3390/biom14081028</pub-id><pub-id pub-id-type="pmid">39199415</pub-id>
</mixed-citation></ref></ref-list></back></article>